Camurati–Engelmann disease
Rare genetic disorder causing progressive bone thickening and pain.
Camurati–Engelmann disease (CED), also called progressive diaphyseal dysplasia, is an extremely rare genetic condition passed down in an autosomal dominant pattern. It primarily affects the skeleton, leading to characteristic bone abnormalities. The condition usually emerges during childhood and worsens slowly over time. Although there is no cure, treatments are available.
People with CED often have bones that are significantly thickened, especially along the shafts of the long bones—a feature known as diaphyseal dysplasia. The skull bones can also thicken, narrowing the passages that carry nerves and blood vessels, which may result in sensory problems, blindness, or hearing loss. The disease is considered inherited, but many affected individuals have no family history of it.
Common symptoms include chronic bone pain in the arms or legs, muscle weakness (myopathy), and a waddling gait. Patients may also experience fatigue, muscle spasms, headaches, difficulty gaining weight, and delayed puberty. Some have an abnormal or missing tibia, flat feet, or scoliosis. The abnormal hardening of bones, called sclerosis, can affect the base of the skull, hands, feet, or jaw, causing ongoing pain. This pain is described in various ways: a hot, electric stabbing sensation; a growing pressure around the bones, especially before electrical storms; or a constant ache radiating through several long bones at once. Joints such as hips, wrists, and knees may lock up, becoming stiff, immobile, and sore—particularly when climbing stairs, writing for long periods, or during cold weather. The waddling gait is medically distinct: a broad-based, duck-like walk where the pelvis drops on the side of the raised leg, with a forward curve in the lower back and a noticeable body swing.
Flare-ups of severe pain can be unpredictable and exhausting, lasting from a few hours to several weeks. These episodes often cause myopathy and severe sleep deprivation. During flare-ups, patients may need a wheelchair or help with daily tasks like dressing, showering, mobility, shopping, meal preparation, or lifting heavy items, and they may be bedridden or housebound for days or weeks. Triggers for flare-ups include growth spurts, stress, exhaustion, exercise, prolonged standing or walking, illness, infection, accidental injury, surgery or anaesthesia, cold weather, electrical storms, and sudden changes
- field
- Medical genetics
- known_for
- Autosomal dominant disorder causing diaphyseal dysplasia and bone pain
- type
- Genetic disease
- inheritance
- Autosomal dominant
- gene
- TGFB1 on chromosome 19q13
Lore & Background
Camurati–Engelmann disease is named for M. Camurati and G. Engelmann. It is caused by autosomal dominant mutations in the gene TGFB1, localized at chromosome 19q13. The disease is considered inherited, though many patients have no previous family history. It is classified into two forms: Type 1 is associated with TGFB1, while Type 2 is not, with some speculation that Type 2 may be a phenotypic variation of hyperostosis generalisata with striations of the bones.
Patients typically have heavily thickened bones, especially along the shafts of the long bones. The skull bones may become thickened, narrowing passages that carry nerves and blood vessels, possibly leading to sensory deficits, blindness, or deafness. Symptoms include chronic bone pain in the legs or arms, muscle weakness, a waddling gait, fatigue, headache, difficulty gaining weight, and delay in puberty. Some patients have an abnormal or absent tibia, flat foot, or scoliosis. Pain is especially severe during unpredictable flare-ups that can last from hours to weeks, often causing myopathy and sleep deprivation.
Treatment includes glucocorticosteroids, which help with pain and fatigue and may correct some radiographic abnormalities. Alternative treatments such as massage, relaxation techniques, gentle stretching, and heat therapy are used alongside pain medications. Many patients require analgesics, muscle relaxants, or sleep-inducing medication, especially during winter. Notable person John Belluso, a writer for the CBS television show Ghost Whisperer, used a wheelchair from age 13 because of Camurati–Engelmann syndrome and died at age 36.
Reader's Guide
Camurati–Engelmann disease is significant as a rare genetic disorder that illustrates the role of TGFB1 mutations in bone metabolism. The disease's autosomal dominant inheritance pattern, combined with frequent de novo cases, highlights the importance of genetic counseling. Its classification into two types, with Type 1 linked to TGFB1 and Type 2 remaining speculative, underscores ongoing uncertainties in medical genetics. The condition's progressive nature and unpredictable flare-ups, which can cause severe pain and disability, emphasize the need for multidisciplinary management including pain control, physical therapy, and monitoring for secondary issues such as vision or hearing loss. The disease also serves as a model for understanding how mutations in the latency-associated peptide of TGFB1 can disrupt osteoblast and osteoclast regulation, leading to increased bone formation. While glucocorticosteroids offer some relief, the lack of a cure and the potential for severe symptoms make CED a challenging condition that requires lifelong care. The case of John Belluso brings attention to the impact of the disease on quality of life and career.
Did You Know?
- Camurati–Engelmann disease is also known as progressive diaphyseal dysplasia.
- The disease is caused by autosomal dominant mutations in the gene TGFB1 on chromosome 19q13.
- Pain flare-ups can last from a few hours to several weeks and may be exacerbated by cold weather, stress, or infection.
- Writer John Belluso used a wheelchair from age 13 due to Camurati–Engelmann syndrome and died at age 36.
More in Diseases named after discoverers 1-24
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record